A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis. [electronic resource]
Producer: 20050504Description: 166-8 p. digitalISSN:- 1352-4585
- Administration, Oral
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Bromelains -- administration & dosage
- Double-Blind Method
- Female
- Humans
- Magnetic Resonance Imaging
- Male
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Placebos
- Recurrence
- Rutin -- administration & dosage
- Treatment Outcome
- Trypsin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.